- Research works
- 33 ▲ 74% vs 2013–17
- Citations
- 807 24.3 per fractional work
- Top-10% rate
- 9.3% record average 16.5%
- Open access
- 52% world 28%
Not ranked overall: Interface Biologics (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 48.2×. Every wedge is a field page.
Which keywords describe research at Interface Biologics (Canada)?
By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Immunotherapy, Tumor Regression, Cancer Immunotherapy, Lymphoma, AAV, CAR T Cells and Chimeric Antigen Receptor.
- Nanocomposites
- Stunting
- Inflammation
- Chimeric Antigen Receptor
- Biomedical Applications
- Lymphoma
- Cancer Immunotherapy
- Immunotherapy
- Gene Therapy
- Tumor Regression
- Epidemiology
- AAV
- CAR T Cells
- Viral Vectors
- Maternal Health
- Drug Delivery
- Public Health
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 17 words, with their numbers
- Gene Therapy3▲ 32×3 topics
- Immunotherapy3▲ 12×3 topics
- Tumor Regression2▲ 86×2 topics
- Cancer Immunotherapy2▲ 44×2 topics
- Epidemiology2▲ 1.39×12 topics
- Lymphoma2▲ 34×2 topics
- AAV2▲ 76×1 topic
- Biomedical Applications2▲ 4.5×7 topics
- CAR T Cells2▲ 114×1 topic
- Chimeric Antigen Receptor2▲ 114×1 topic
- Viral Vectors2▲ 76×1 topic
- Inflammation1▲ 1.77×7 topics
- Maternal Health1▲ 30×1 topic
- Stunting1▲ 53×1 topic
- Drug Delivery1▲ 8.3×6 topics
- Nanocomposites1▲ 4.9×4 topics
- Public Health1▲ 2.3×3 topics
Which research topics does Interface Biologics (Canada) publish most on?
By volume in 2022–2025: Consumer Retail Behavior Studies, Animal health and immunology, Hemophilia Treatment and Research and Protein purification and stability.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Consumer Retail Behavior Studies Marketing 0 works
- 2 Animal health and immunology Small Animals 0 works
- 3 Hemophilia Treatment and Research Hematology 0 works
- 4 Protein purification and stability Molecular Biology 0 works
- 5 Cleft Lip and Palate Research Genetics 0 works
- 6 Invertebrate Immune Response Mechanisms Immunology 0 works
- 7 Nicotinic Acetylcholine Receptors Study Molecular Biology 0 works
- 8 Ion Transport and Channel Regulation Molecular Biology 0 works
- 9 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 10 Receptor Mechanisms and Signaling Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Interface Biologics (Canada)'s research output changed?
Output in 2018–2022 was 74% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Toronto
- University of Toronto
- York University
- Hospital for Sick Children
- Toronto Metropolitan University
- University Health Network
- Sunnybrook Health Science Centre
- St. Michael's Hospital
- Princess Margaret Cancer Centre
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.